Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,845 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
2014 ACC/AHA Key Data Elements and Definitions for Cardiovascular Endpoint Events in Clinical Trials: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Cardiovascular Endpoints Data Standards).
Hicks KA, Tcheng JE, Bozkurt B, Chaitman BR, Cutlip DE, Farb A, Fonarow GC, Jacobs JP, Jaff MR, Lichtman JH, Limacher MC, Mahaffey KW, Mehran R, Nissen SE, Smith EE, Targum SL; ACC/AHA TASK FORCE ON CLINICAL DATA STANDARDS MEMBERS. Hicks KA, et al. Among authors: mehran r. J Nucl Cardiol. 2015 Oct;22(5):1041-144. doi: 10.1007/s12350-015-0209-1. J Nucl Cardiol. 2015. PMID: 26204990 No abstract available.
Feasibility and implications of an early discharge strategy after percutaneous intervention with abciximab in acute myocardial infarction (the CADILLAC Trial).
Kandzari DE, Tcheng JE, Cohen DJ, Bakhai A, Grines CL, Cox DA, Effron M, Stuckey T, Griffin JJ, Turco M, Carroll JD, Fahy M, Mehran R, Stone GW; CADILLAC Investigators. Kandzari DE, et al. Among authors: mehran r. Am J Cardiol. 2003 Oct 1;92(7):779-84. doi: 10.1016/s0002-9149(03)00882-8. Am J Cardiol. 2003. PMID: 14516875 Clinical Trial.
Outcomes of bail-out stenting for suboptimal balloon angioplasty during primary intervention in acute myocardial infarction (The CADILLAC trial).
Ashby DT, Aymong EA, Grines CL, Cox DA, Garcia E, Mehran R, Tcheng JE, Griffin JJ, Guagliumi G, Stuckey T, Carroll JD, Turco M, Lansky AJ, Stone GW; CADILLAC trial. Ashby DT, et al. Among authors: mehran r. Am J Cardiol. 2003 Nov 1;92(9):1095-8. doi: 10.1016/j.amjcard.2003.06.006. Am J Cardiol. 2003. PMID: 14583363 Clinical Trial.
Relation between late patency of the infarct-related artery, left ventricular function, and clinical outcomes after primary percutaneous intervention for acute myocardial infarction (CADILLAC trial).
Halkin A, Aymong E, Cox DA, Mehran R, Lansky AJ, Fahy M, Weisz G, Garcia E, Tcheng JE, Grines CL, Stone GW. Halkin A, et al. Among authors: mehran r. Am J Cardiol. 2004 Feb 1;93(3):349-53. doi: 10.1016/j.amjcard.2003.10.019. Am J Cardiol. 2004. PMID: 14759389
Predictors of and outcomes of early thrombosis following balloon angioplasty versus primary stenting in acute myocardial infarction and usefulness of abciximab (the CADILLAC trial).
Dangas G, Aymong ED, Mehran R, Tcheng JE, Grines CL, Cox DA, Garcia E, Griffin JJ, Guagliumi G, Stuckey T, Lansky AJ, Stone GW; CADILLAC Investigators. Dangas G, et al. Among authors: mehran r. Am J Cardiol. 2004 Oct 15;94(8):983-8. doi: 10.1016/j.amjcard.2004.06.050. Am J Cardiol. 2004. PMID: 15476608 Clinical Trial.
Outcomes of patients consented but not randomized in a trial of primary percutaneous coronary intervention in acute myocardial infarction (the CADILLAC registry).
Halkin A, Stone GW, Grines CL, Cox DA, Stuckey TD, Garcia E, Guagliumi G, Mehran R, Rutherford BD, Griffin JJ, Na Y, Tcheng JE, Turco M. Halkin A, et al. Among authors: mehran r. Am J Cardiol. 2005 Dec 15;96(12):1649-55. doi: 10.1016/j.amjcard.2005.07.088. Epub 2005 Oct 21. Am J Cardiol. 2005. PMID: 16360352
1,845 results